Search results
Results from the WOW.Com Content Network
BMJ Open is a peer-reviewed open access medical journal that is dedicated to publishing medical research from all disciplines and therapeutic areas. [1] It is published by BMJ and considers all research study types, from protocols through phase I trials to meta-analyses, including small, specialist studies, and negative studies.
The BMJ allows complete free access for visitors from economically disadvantaged countries as part of the HINARI initiative. [citation needed] In October 2008 The BMJ announced that it would become an open access journal for research articles. A subscription continued to be required for access to other articles. [35]
BMJ Group is a British publisher of medical journals, and healthcare knowledge provider of clinical decision tools, online educational resources, and events. Established in 1840, the company is owned by the British Medical Association .
Changes in the eye can help predict other health concerns in the body, such as diabetes and high blood pressure. A new study has identified a set of 29 vascular health indicators on the retina ...
BMJ. BMJ is a peer-reviewed medical journal. It is one of the world's oldest general medical journals and has been described as among the most prestigious. It was originally called the British Medical Journal. BMJ is offering 50 accounts to active medical editors.
A new opioid-free pain medication was approved by the U.S. Food and Drug Administration (FDA) on Thursday, marking a non-addictive alternative for patients. Journavx (suzetrigine), made by Vertex ...
The report also revealed that more than half of U.S. adults (57%) have type 2 diabetes or prediabetes. "Although we have made a lot of progress against cardiovascular disease in the past few ...
BMJ Global Health is a peer-reviewed medical journal which publishes research articles and reviews about global health issues. The journal was established in 2016 [1] and is published by the BMJ Publishing Group. [2] As of 2024, its editor-in-chief is Mark G. Shrime. [3]